Physician profile
Bilal Farhat
NPI 1245645258
$2,806.84
in general payments reported to CMS, 2019-2025
21 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.81 · 2020: $221 · 2021: $296 · 2022: $521 · 2023: $606 · 2024: $598 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,696.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $597.19 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $503.11 | 2022-2025 | Envista Mx60 Iol, Envista Envy Iol, Xiidra |
| Glaukos Corporation | $383.49 | 2021-2023 | Kxl System (Not Refurbished), Photrexa Cross-Linking Kit |
| Alcon Vision LLC | $349.52 | 2020-2025 | Clareon, Clareon Panoptix Pro |
| Allergan, INC. | $229.14 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $183.40 | 2025 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Abbvie INC. | $92.10 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $69.18 | 2022-2025 | |
| The Cameron-Ehlen Group, INC. | $47.53 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.28 | 2021 | |
| Novartis Pharmaceuticals Corporation | $42.59 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $40.33 | 2024 | Iolmaster 700 |
| Dompe US, INC. | $40.30 | 2025 | Oxervate |
| Rxsight INC | $38.90 | 2022-2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal) |
| Sight Sciences, INC. | $34.11 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $19.40 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Mallinckrodt Hospital Products INC. | $18.93 | 2024 | Acthar |
| Optos, INC. | $18.47 | 2020 | |
| Aerie Pharmaceuticals, INC. | $17.63 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $16.84 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bilal Farhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.